A total of 4 institutions have reported a stake in Adicet Bio, Inc. (NASDAQ:ACET) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 30 Sep, 2025 | 11,447,140 | 0 | 0.00% | $9,274,473.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 8,223,612 | 0 | 0.00% | $6,662,770.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 7,541,000 | 0 | 0.00% | $6,109,718.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 3,751,617 | -481 | -0.01% | $3,039,560.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 3,272,522 | 0 | 0.00% | $2,650,743.00 |
| Carlyle Group Inc. | 30 Sep, 2025 | 2,948,718 | 0 | 0.00% | $2,388,756.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 2,265,491 | 190,887 | 9.20% | $1,835.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 1,828,949 | 675,133 | 58.51% | $1,481,814.00 |
| REGENERON PHARMACEUTICALS, INC. | 30 Sep, 2025 | 968,183 | 0 | 0.00% | $784,422.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 901,600 | 0 | 0.00% | $730,476.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 854,568 | 341,761 | 66.65% | $692,371.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 780,982 | 214,943 | 37.97% | $632,752.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 706,334 | 0 | 0.00% | $572,440.00 |
| Alyeska Investment Group, L.P. | 30 Sep, 2025 | 655,665 | 0 | 0.00% | $531,220.00 |
| RBF Capital, LLC | 30 Sep, 2025 | 617,319 | 0 | 0.00% | $500,152.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 585,377 | -14,110 | -2.35% | $474,272.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 583,948 | 583,948 | 0.00% | $473,115.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 565,953 | -26,374 | -4.45% | $458,535.00 |
| Schonfeld Strategic Advisors LLC | 30 Sep, 2025 | 479,108 | -1,400,987 | -74.52% | $388,171.00 |
| JOHNSON & JOHNSON | 30 Sep, 2025 | 364,472 | 0 | 0.00% | $295,295.00 |